International challenge to model the long-range transport of radioxenon released from medical isotope production to six Comprehensive Nuclear-Test-Ban Treaty monitoring stations

Maurer, C.*; Bar, J.*; Kusmierczyk-Michulec, J.*; Crawford, A.*; Eslinger, P. W.*; Seibert, P.*; Orr, B.*; Philipp, A.*; Ross, O.*; Generoso, S.*; Achim, P.*; Schoeppner, M.*; Malo, A.*; Ringbom, A.*; Saunier, O.*; Qulo, D.*; Mathieu, A.*; Kijima, Yuichi ; Stein, A.*; Chai, T.*; Ngan, F.*; Leadbetter, S. J.*; Meutter, P. D.*; Delcloo, A.*; Britton, R.*; Davies, A.*; Glascoe, L. G.*; Lucas, D. D.*; Simpson, M. D.*; Vogt, P.*; Kalinowski, M.*; Bowyer, T. W.*

It is very important to understand the impact for CTBT stations caused by radioxenon emitted from medical isotope production facilities for detection of underground nuclear tests. Predictions of the impact on six CTBT radionuclide stations in the Southern Hemisphere of radioxenon emitted from the medical isotope production facility in Australia were carried out by participants from ten nations using ATM (Atmospheric Transport Modeling) based on the emission data of radioxenon from this facility, as part of study on impact of radioxenon emitted from medical isotope production facilities on CTBT radionuclide stations.